Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie Reports Second-Quarter 2018 Financial Results
- Reports Second-Quarter Diluted EPS of $1.26 on a GAAP Basis; Adjusted Diluted EPS of $2.00 Reflects Growth of 40.8 Percent - Delivers Second-Quarter Net Revenues of $8.278 Billion on a GAAP Basis; Adjusted Net Revenues of $8.258 Billion Increased 17.1 Percent on an Operational Basis -
Toggle Summary AbbVie to Host Second-Quarter 2018 Earnings Conference Call
NORTH CHICAGO, Ill. , July 10, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its second-quarter 2018 financial results on Friday, July 27, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , June 14, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.96 per share.  The cash dividend is payable Aug. 15, 2018 to stockholders of record at the close of business on July 13, 2018 .
Toggle Summary AbbVie Announces Final Results of Tender Offer
NORTH CHICAGO, Ill. , June 4, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) today announced the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . AbbVie has accepted for purchase 72,815,534 shares of its common
Toggle Summary AbbVie Announces Updated Preliminary Results of Tender Offer
NORTH CHICAGO, Ill. , May 30, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) today announced the preliminary results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . This update replaces the preliminary results announced at
Toggle Summary AbbVie Announces Preliminary Results of Tender Offer
NORTH CHICAGO, Ill. , May 30, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the preliminary results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . Based on the preliminary count by Computershare Trust Company,
Toggle Summary AbbVie to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , May 29, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Goldman Sachs 39 th Annual Global Healthcare Conference on Tuesday, June 12, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will
Toggle Summary AbbVie to Present at the Jefferies 2018 Global Healthcare Conference
NORTH CHICAGO, Ill. , May 22, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018 . Bill Chase , executive vice president and chief financial officer, will present
Toggle Summary AbbVie to Present at the UBS Global Healthcare Conference
NORTH CHICAGO, Ill. , May 8, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the UBS Global Healthcare Conference on Tuesday, May 22, 2018 . Bill Chase , executive vice president and chief financial officer, will present at 7:30 a.m.
Toggle Summary AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference
NORTH CHICAGO, Ill. , May 2, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 2018 Bank of America Merrill Lynch Health Care Conference on Wednesday, May 16, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will